FDA approves the first fecal microbiota product, Rebyota. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. It is for used after an individual has completed antibiotic treatment for recurrent CDI.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bMCU2OF
No comments:
Post a Comment